The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Elevated Levels of Epidermal Growth Factor Receptor/c-erbB2 Heterodimers Mediate an Autocrine Growth Regulatory Pathway in Tamoxifen-Resistant MCF-7 Cells
Abstract
The development of acquired resistance to antihormonal agents in breast cancer is a major therapeutic problem. We have developed a tamoxifen-resistant (TAM-R) MCF-7 breast cancer cell line to investigate the mechanisms behind this condition. Both epidermal growth factor receptor (EGFR) and c-erbB2 mRNA and protein expression were increased in TAM-R compared with wild-type MCF-7 cells, whereas comparable levels of c-erbB3 mRNA and protein were expressed in both cell lines. Under basal conditions, phosphorylated EGFR/c-erbB2, EGFR/c-erbB3 but not c-erbB2/c-erbB3 receptor heterodimers were detected in TAM-R cells in association with increased levels of phosphorylated extracellular-signal regulated kinase 1/2 (ERK1/2). Both cell lines were capable of generating a range of EGFR-specific ligands and increased expression of transforming growth factor α was observed in TAM-R cells. Treatment of TAM-R cells with ZD1839 (Iressa) or trastuzumab (Herceptin) blocked c-erbB receptor heterodimer formation and phosphorylation, reduced ERK1/2 activity, and strongly inhibited cell growth. The MAPK kinase inhibitor PD098059 specifically reduced phosphorylated ERK1/2 levels and inhibited TAM-R growth. All three agents abolished ERK1/2 activity in wild-type cells but caused only small reductions in cell proliferation. These results demonstrate that TAM-R MCF-7 cell growth is mediated by the autocrine release and action of an EGFR-specific ligand inducing preferential EGFR/c-erbB2 dimerization and downstream activation of the ERK pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Signal transduction by receptors with tyrosine kinase activity
Ullrich, A., & Schlessinger, J. (1990) · Cell · doi:10.1016/0092-8674(90)90801-k · Cited by 5,435
Epidermal growth factor-related peptides and their receptors in human malignancies
Salomon, D. S., Brandt, R., Ciardiello, F., & Normanno, N. (1995) · Critical Reviews in Oncology/Hematology · doi:10.1016/1040-8428(94)00144-i · Cited by 2,690
A synthetic inhibitor of the mitogen-activated protein kinase cascade.
Dudley, D. T., Pang, L., Decker, S. J., Bridges, A. J., & Saltiel, A. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7686 · Cited by 2,679
Olayioye, M. A. (2000) · The EMBO Journal · doi:10.1093/emboj/19.13.3159 · Cited by 2,434
Graus-Porta, D. (1997) · The EMBO Journal · doi:10.1093/emboj/16.7.1647 · Cited by 1,590
Tzahar, E., Waterman, H., Chen, X., Levkowitz, G., Karunagaran, D., Lavi, S., Ratzkin, B. J., & Yarden, Y. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.10.5276 · Cited by 1,036
Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu
Benz, C. C., Scott, G. K., Sarup, J. C., Johnson, R. M., Tripathy, D., Coronado, E., Shepard, H. M., & Osborne, C. K. (1992) · Breast Cancer Research and Treatment · doi:10.1007/bf01961241 · Cited by 750
Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity.
Guy, P. M., Platko, J. V., Cantley, L. C., Cerione, R. A., & Carraway, K. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.17.8132 · Cited by 698 · cited 1×
“The formation of c-erbB3/c-erbB3 homodimers is unlikely as this receptor is kinase impaired and thus requires transphosphorylation by other c-erbB family members (58).”
BackgroundMoulder, S. L., Yakes, F. M., Muthuswamy, S. K., Bianco, R., Simpson, J. F., & Arteaga, C. L. (2001) · PubMed · Cited by 597
Albanell, J., Rojo, F., Averbuch, S., Feyereislova, A., Mascaro, J. M., Herbst, R. S., LoRusso, P. M., Rischin, D., Sauleda, S., Gee, J., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.110 · Cited by 528
Self-citationAll ErbB Receptors Other Than the Epidermal Growth Factor Receptor Are Endocytosis Impaired
Baulida, J., Kraus, M. H., Alimandi, M., Fiore, P. P. D., & Carpenter, G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.9.5251 · Cited by 454
Lenferink, A. E. G. (1998) · The EMBO Journal · doi:10.1093/emboj/17.12.3385 · Cited by 413
Cellular and Molecular Pharmacology of Antiestrogen Action and Resistance
Clarke, R., Leonessa, F., Welch, J. N., & Skaar, T. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01479-0 · Cited by 397
Wright, C., Nicholson, S., Angus, B., Sainsbury, J., Farndon, J., Cairns, J., Harris, A., & Horne, C. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.22 · Cited by 379
Kurokawa, H., Lenferink, A. E. G., Simpson, J. F., Pisacane, P. I., Sliwkowski, M. X., Forbes, J. T., & Arteaga, C. L. (2000) · PubMed · Cited by 363
Kokai, Y., Myers, J. N., Wada, T., Brown, V. I., LeVea, C. M., Davis, J. G., Dobashi, K., & Greene, M. I. (1989) · Cell · doi:10.1016/0092-8674(89)90843-x · Cited by 309
Beerli, R. R., & Hynes, N. E. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.11.6071 · Cited by 308
ZD1839 (???Iressa???)*,??? as an Anticancer Agent
Baselga, J., & Averbuch, S. D. (2000) · Drugs · doi:10.2165/00003495-200060001-00004 · Cited by 301
Endocytosis of growth factor receptors
Sorkin, A., & Waters, C. M. (1993) · BioEssays · doi:10.1002/bies.950150603 · Cited by 272
McClelland, R. A., Barrow, D., Madden, T., Dutkowski, C. M., Pamment, J., Knowlden, J. M., Gee, J. M. W., & Nicholson, R. I. (2001) · Endocrinology · doi:10.1210/en.142.7.2776 · Cited by 258
Self-citationMechanism of action of trastuzumab and scientific update
BASELGA, J. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90276-3 · Cited by 258
Gee, J. M. W., Robertson, J. F. R., Ellis, I. O., & Nicholson, R. I. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(20010720)95:4<247::aid-ijc1042>3.0.co;2-s · Cited by 249
Self-citationGee, J. M. W., Ellis, I. O., Robertson, J. F. R., Willsher, P., McClelland, R. A., Hewitt, K. N., Blamey, R. W., & Nicholson, R. I. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910640410 · Cited by 204
Self-citationMeasurement of steroid hormone receptors in breast cancer patients on tamoxifen
Encarnaci�n, C. A., Ciocca, D. R., McGuire, W. L., Clark, G. M., Fuqua, S. A. W., & Osborne, C. K. (1993) · Breast Cancer Research and Treatment · doi:10.1007/bf00665801 · Cited by 194
Nicholson, R. I., McClelland, R. A., Gee, J. M. W., Manning, D. L., Cannon, P., Robertson, J. F. R., Ellis, I. O., & Blamey, R. W. (1994) · Breast Cancer Research and Treatment · doi:10.1007/bf00666187 · Cited by 190
Self-citationNicholson, R. I., McClelland, R. A., Finlay, P., Eaton, C. L., Gullick, W. J., Dixon, A. R., Robertson, J. F. R., Blamey, R. W., & Ellis, I. O. (1993) · European Journal of Cancer · doi:10.1016/s0959-8049(05)80215-1 · Cited by 178
Self-citationMechanism of 17-β-Estradiol-induced Erk1/2 Activation in Breast Cancer Cells
Keshamouni, V. G., Mattingly, R. R., & Reddy, K. B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202351200 · Cited by 174
Shim, W.-S., Conaway, M., Masamura, S., Yue, W., Wang, J.-P., Kumar, R., & Santen, R. J. (2000) · Endocrinology · doi:10.1210/endo.141.1.7270 · Cited by 169
Liu, Y., El-Ashry, D., Chen, D., Ding, I. Y. F., & Kern, F. G. (1995) · Breast Cancer Research and Treatment · doi:10.1007/bf00665783 · Cited by 163
Lykkesfeldt, A. E., Madsen, M. W., & Briand, P. (1994) · PubMed · Cited by 160
Involvement of steroid hormone and growth factor cross-talk in endocrine response in breast cancer.
Nicholson, R. I., McClelland, R. A., Robertson, J. F., & Gee, J. M. (1999) · Endocrine-related cancer · doi:10.1677/erc.0.0060373 · Cited by 160
Self-citationGee, J. M. W., Robertson, J. F. R., Ellis, I. O., Willsher, P., McClelland, R. A., Hoyle, H. B., Kyme, S. R., Finlay, P., Blamey, R. W., & Nicholson, R. I. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910590508 · Cited by 160
Self-citationvan den Br�le, F. A., Waltregny, D., Liu, F., & Castronovo, V. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20000720)89:4<384::aid-ijc11>3.0.co;2-r · Cited by 158
Oestrogen receptor: a stable phenotype in breast cancer
Robertson, J. F. R. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.2 · Cited by 143
Donovan, J. C. H., Milic, A., & Slingerland, J. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106448200 · Cited by 137
Expression of c-erbB receptors, heregulin and oestrogen receptor in human breast cell lines
DeFazio, A., Chiew, Y.-E., Sini, R. L., Janes, P. W., & Sutherland, R. L. (2000) · International Journal of Cancer · Cited by 134
Knowlden, J. M., Gee, J. M. W., Seery, L. T., Farrow, L., Gullick, W. J., Ellis, I. O., Blamey, R. W., Robertson, J. F. R., & Nicholson, R. I. (1998) · Oncogene · doi:10.1038/sj.onc.1202107 · Cited by 129
Self-citationThe type I growth factor receptors in human breast cancer
Rajkumar, T., & Gullick, W. J. (1994) · Breast Cancer Research and Treatment · doi:10.1007/bf00666177 · Cited by 123
Tang, C. K., Pérez, C., Grunt, T. W., Waibel, C., Cho, C., & Lupu, R. (1996) · PubMed · Cited by 120
Mechanisms of tamoxifen resistance
Osborne, C. K., & Fuqua, S. A. W. (1994) · Breast Cancer Research and Treatment · doi:10.1007/bf00666205 · Cited by 120
Coutts, A. S., & Murphy, L. C. (1998) · PubMed · Cited by 110
van Agthoven, T., van Agthoven, T. L., Portengen, H., et al. (1992) · PubMed · Cited by 106
El‐Ashry, D., Miller, D. L., Kharbanda, S., Lippman, M. E., & Kern, F. G. (1997) · Oncogene · doi:10.1038/sj.onc.1201198 · Cited by 104
Brünner, N., Frandsen, T. L., Holst‐Hansen, C., Bei, M., Thompson, E. W., Wakeling, A. E., Lippman, M. E., & Clarke, R. C. (1993) · PubMed · Cited by 103
Self-citationFavoni, R. E., & de Cupis, A. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01446-7 · Cited by 98
Nicholson, R. I., & Gee, J. M. W. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.0954 · Cited by 96
Self-citationMiller, D. L., El‐Ashry, D., Cheville, A. L., Liu, Y., McLeskey, S. W., & Kern, F. G. (1994) · PubMed · Cited by 93
Dougall, W. C., Qian, X., & Greene, M. I. (1993) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240530108 · Cited by 78
Take Your Partners, Please — Signal Diversification by the erbB Family of Receptor Tyrosine Kinases
Daly, R. J. (1999) · Growth Factors · doi:10.3109/08977199909069144 · Cited by 61
Induction of estrogen independence of ZR-75-1 human breast cancer cells by epigenetic alterations.
van Agthoven, T., van Agthoven, T. L., Dekker, A., et al. (1994) · Molecular Endocrinology · doi:10.1210/mend.8.11.7533260 · Cited by 50
McClelland, R. A., Gee, J. M. W., Francis, A., Robertson, J. F. R., Blarney, R. W., Wakeling, A. E., & Nicholson, R. I. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(95)00517-x · Cited by 48
Self-citationAa, E.-Z., & van den Berg, H. W. (1999) · Cancer Letters · doi:10.1016/s0304-3835(99)00167-6 · Cited by 32
Knowlden, J. M., Gee, J. M. W., Bryant, S., McClelland, R. A., Manning, D. L., Mansel, R. E., Ellis, I. O., Blamey, R. W., Robertson, J. F. R., & Nicholson, R. I. (1997) · PubMed · Cited by 30
Self-citation
Cited by
Differential oestrogen receptor binding is associated with clinical outcome in breast cancer
Ross-Innes, C. S., Stark, R., Teschendorff, A. E., Holmes, K. A., Ali, H. R., Dunning, M. J., Brown, G. D., Gojis, O., Ellis, I. O., Green, A. R., et al. (2012) · Nature · doi:10.1038/nature10730 · Cited by 2,173
Estrogen receptors: how do they signal and what are their targets
Heldring, N., Pike, A., Andersson, S., Matthews, J., Cheng, G., Hartman, J., Tujague, M., Ström, A., Treuter, E., Warner, M., et al. (2007) · Physiological Reviews · doi:10.1152/physrev.00026.2006 · Cited by 1,857
Pioneer transcription factors: establishing competence for gene expression
Zaret, K. S., & Carroll, J. S. (2011) · Genes & Development · doi:10.1101/gad.176826.111 · Cited by 1,589
Differential Oestrogen Receptor Binding is Associated with Clinical Outcome in Breast Cancer
Stark, R. (2012) · Lecture Notes in Computer Science · doi:10.1007/978-3-642-29627-7_30 · Cited by 1,403
Biological determinants of endocrine resistance in breast cancer
Musgrove, E. A., & Sutherland, R. L. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2713 · Cited by 1,252
Metadata
- Authors
- Knowlden, J. M., Hutcheson, I. R., Jones, H. E., Madden, T., Gee, J. M. W., Harper, M. E., Barrow, D., Wakeling, A. E., & Nicholson, R. I.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2003-03-01
- Volume
- 144
- Issue
- 3
- Pages
- 1032-1044
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2025005089
- Cited by
- 521
- References
- 54
- FWCI
- 12.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.